Search
Close this search box.

Abstract

Aim: To provide more efficient and timely immunogenicity testing service to support routine patient care, the original complex testing algorithm for evaluation of anti-velaglucerase alfa antibodies has been simplified and individual methods (screen, confirm, titer, neutralizing antibody [NAb] and IgE) have been redeveloped/optimized and validated. Results: To compare the performance of different methods, 50 velaglucerase alfa-treated patient samples were analyzed using both old and new methods for the presence of antidrug antibodies (ADAs) and 31 ADA-positive samples were analyzed for neutralizing capacity. The ADA and NAb statuses are almost identical from both methods and both ADA and NAb titer results are highly correlated with a Spearman’s correlation of 0.96 and 0.86, respectively. Conclusion: The original and new testing methods can be considered interchangeable for the measurement of total and neutralizing anti-velaglucerase alfa antibodies.

Keywords:

  • ADAs
  • antidrug antibodies
  • comparative analysis
  • Gaucher disease
  • NAbs
  • neutralizing antibodies
  • velaglucerase alfa
Scroll to Top